Precision Optics Corp Inc(POCI) Price Forecast & Company Analysis. P/E · Dividend · Earnings · Price Target · RSI · MACD | US Stocks Today
Full metrics table
| Index | - | P/E | - | EPS (ttm) | -0.47 | Insider Own | 27.59% | Shs Outstand | 11.0M | Perf Week | 10.34% |
| Market Cap | 0.05B | Forward P/E | 160 | EPS next Y | 110% | Insider Trans | - | Shs Float | 8.0M | Perf Month | 7.62% |
| Enterprise Value | 0.05B | PEG | - | EPS next Q | -0.13 | Inst Own | 33.32% | Short Float | 0.05% | Perf Quarter | 14.01% |
| Income | -0.00B | P/S | 1.67 | EPS this Y | 30.23% | Inst Trans | -3.51% | Short Ratio | 0.08 | Perf Half Y | 13.48% |
| Sales | 0.03B | P/B | 2.59 | EPS next 5Y | - | ROA | -13.93% | Short Interest | 0.00M | Perf YTD | 14.7% |
| Book/sh | 1.85 | P/C | 5.35 | EPS past 3/5Y | -155.54% -78.93% | ROE | -22.26% | 52W High | -21.95% ($6.15) | Perf Year | 11.63% |
| Cash/sh | 0.9 | P/FCF | - | Sales past 3/5Y | 14.43% 24.19% | ROIC | -15.44% | 52W Low | 35.21% ($3.55) | Perf 3Y | -19.87% |
| Dividend Est. | - | EV/EBITDA | - | EPS Y/Y TTM | 45.07% | Gross Margin | 17.22% | Volatility(W/M) | 4.52% 3.91% | Perf 5Y | -29.2% |
| Dividend TTM | - | EV/Sales | 1.49 | Sales Y/Y TTM | 65.16% | Oper. Margin | -11.13% | ATR (14) | 0.19 | Perf 10Y | 247.83% |
| Dividend Ex-Date | - | Quick Ratio | 1.84 | EPS Q/Q | 94.79% | Profit Margin | -11.51% | RSI (14) | 65.32 | Recom | 1 |
| Dividend Gr. 3/5Y | - | Current Ratio | 2.28 | Sales Q/Q | 41.95% | SMA20 | 7.8% ($4.45) | Beta | 0.23 | Target Price | $8 |
| Payout | - | Debt/Eq | 0.2 | Earnings | 2026/9/28 | SMA50 | 8.53% ($4.42) | Rel Volume | 0.64 | Prev Close | $4.65 |
| Employees | 108 | LT Debt/Eq | 0.16 | EPS/Sales Surpr. | 83.33% 23.58% | SMA200 | 3.76% ($4.63) | Avg Volume(3M) | 0.05M | Price | $4.8 |
| IPO | 1992/1/16 | Option/Short | No/Yes | Trades | 230 | Volume | 31,437 | Change | 3.23% |
🔬 Precision Optics () is a company that designs and manufactures ultra-compact optical components for medical endoscopes and single-use endoscope assemblies. Leveraging its expertise in microscopes and optical systems, the company is a primary supplier of single-use endoscopes for cystoscopy procedures.
Over the past 1 year, roughly in the middle
22% below its 1-year high.
Traded less than usual. That is 64% of its average volume.
POCI has a sound balance sheet but weak earning power
Of every $100 in sales, $11.13 is lost.
Tap to view numbers
Earnings are growing steadily
Earnings are expected to grow by +30.2% this year.
Tap to view numbers
Relative to sales, it looks cheap
Loss-making, so we compare on sales. For a company selling $100 a year, you would pay $167. Peers typically go for $250.
Tap to view numbers
Not enough quarters to judge yet
Only 1 quarter(s) reported, so no grade yet.
Tap to view numbers
The outlook is positive
Analyst sentiment is Strong Buy.
Tap to view numbers
Holding long would have lost money
Bought 5 years ago, your return today would be -29.2%. The S&P 500 did +63% over the same period.
Tap to view numbers
No dividend
There is no profit to distribute yet.
Ownership looks stable
Institutions hold 33.3%.
Tap to view numbers
Multiple ETFs hold this stock, but only a sliver
Buying this ETF gives you exposure to this stock as well.
It ranks #39 of 51 in the industry
Based on market cap of $53M.
POCI#39 Precision Optics Corp Inc $53M PER - 
DXR#40 Daxor Corp $53M PER 7.4 
HBIO#41 Harvard Bioscience Inc $39M PER - 
DAVI#42 Davion Healthcare Plc $37M PER - 
NEPH#43 Nephros Inc $35M PER 20.7 
FAQ
What kind of company is POCI?
POCI belongs to the Healthcare sector and operates in the Medical Instruments & Supplies industry.
What is the market cap of POCI?
The market cap of POCI is approximately $53M, ranking 4,811 within its sector.
What is the 52-week high and low for POCI?
POCI has recorded a 52-week high of $6.15 and a low of $3.55.
